<< Study explores the link between child sexual abuse and inability to express emotions in adulthood | OSI Systems announces financial results for the first quarter ended September 30, 2009 >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

Analysis of recent trends in medicinal chemistry and its significance in drug discovery

Published on October 27, 2009 at 7:13 AM · No Comments

Reportlinker.com announces that a new market research report is available in its catalogue: Reportlinker Adds Medicinal Chemistry for Drug Discovery: Significance of Recent Trends

A thorough analysis of recent trends in medicinal chemistry and evaluation of their significance for advancing productivity in drug discovery is presented. This report includes:

A critical evaluation of chemical and computational technological modalities, their current and potential value, and their commercial manifestations.

A consideration of market dynamics with an emphasis on outsourcing and user views on the implications of current practices in drug discovery organizations.

Insights gleaned from an extensive literature review, discussions with industry experts, and an opinion survey of personnel active in medicinal chemistry for drug discovery.

Medicinal Chemistry for Drug Discovery: Significance of Recent Trends reviews the state of the art and aims to determine the significance of technology and market trends in medicinal chemistry for advancing productivity in drug discovery. Although the fundamental task of medicinal chemists has not changed drastically over time, the chemical and computational tools and perspectives at their disposal have advanced significantly. One in particular, fragment-based drug design, stands out as promising major improvements in research productivity.

We examine medicinal chemistry-related approaches and methodologies that drug discovery organizations employ in an effort to increase productivity in early drug discovery and decrease attrition at later pipeline stages. Key topics considered include structure-based drug design, fragment-based drug design, natural products-based drug design, diversity-oriented synthesis, and chemogenomics. An overall assessment of the current and potential value of these approaches is presented. Various flavors of computer-aided drug design are also considered, as the complexity and limitations of drug discovery programs that are based on biochemical screens of large compound collections have been major factors in stimulating the growth of this modality.

SOURCE Reportlinker

Posted in: Pharmaceutical News

Tags: , , ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading